Postdoc position Long-COVID (m/w/d)
Nephropathologische Abteilung
Prof. Felix B. Engel
Telefon: 091318535659
Universitätsklinikum Erlangen
Nephropathologische Abteilung
Prof. Felix B. Engel
Telefon: 091318535659
Job-Id: 9462
Nephropathologische Abteilung
Prof. Felix B. Engel
Telefon: 091318535659
Nephropathologische Abteilung
Prof. Felix B. Engel
Telefon: 091318535659
Published since: 21.11.2024
Job-Id: 9462
Nephropathologische Abteilung
Prof. Felix B. Engel
Telefon: 091318535659
Universitätsklinikum Erlangen
Nephropathologische Abteilung
Prof. Felix B. Engel
Telefon: 091318535659
Sounds interesting?
Who we are:
State-of-the-art medicine and nursing care you can rely on
Since being founded in 1815, Universitätsklinikum Erlangen has offered medicine of the highest standard and incorporated the latest insights from medical research and state-of-the-art equipment into diagnosis and therapy. More than 9,600 employees from approximately 50 different occupations are needed to provide the wide range of services offered by Universitätsklinikum Erlangen, ensuring our patients receive the very best care around the clock.
A postdoctoral position is available in the group of Professor Felix B. Engel. The group is highly interdisciplinary and international (3 postdocs, 8 PhDs, 7 technicians). We utilize a large variety of tools such as zebrafish and mouse as model organisms, 3D printing of tissues, hiPSCs, as well as state-of-the-art molecular and cell biology techniques. The Engel group is located in the Translational Research Center of the University Hospital Erlangen. Our laboratory publishes r
Your tasks:
| Background of the project: This position is integrated in the research consortium PERCOLATE. The overall aim of PERCOLATE is to establish a rapid and easy-to-use diagnostic test panel, based on detection of functional autoantibodies targeting G-protein coupled receptors (GPCR-fAAb) in combination with GPCR-fAAb mediated ischaemia-reperfusion parameters, accompanied by profiling of immune cells and viral reactivation in patients with Long-COVID (LC) and Post-Vaccination Syndrome (Post-VAC) for a personalized patients’ stratification and care. Your task will be to advance the method of Wallukat et al., in which primary rat cardiomyocytes were used, to detect the functional active GPCR-AAbs from patients’ sera utilizing hiPSC-derived cardiomyocytes and/or cardiac tissues. Aim 1. Establishment of a hiPSC-derived reporter cell line for fluorescence visualization of GPCR activation by GPCR-fAAbs in hiPSC-cardiomyocytes. Aim 2: Establishment of a hiPSC cell |
Comments:
- Funding: The project is funded by the Ministry of Health. Salary: E13, 100% for 2 years with possible extension (funded until 31.12.2028).
Essential experience/qualifications:
Additionally beneficial are:
| Cardiac tissue engineering, 3D-printing, immunofluorescence analysis, first author publications in high profile journals |